Arcutis Biotherapeutics (NASDAQARQT) Stock Price Expected to Rise, Mizuho Analyst Says

Image for article Arcutis Biotherapeutics (NASDAQARQT) Stock Price Expected to Rise, Mizuho Analyst Says
News Source : ETF Daily News

News Summary

  • Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Mizuho from $19
  • 00 to $20
  • 00 in a research note released on Tuesday
  • They currently have an outperform rating on the stock
  • The company had revenue of $44
  • 76 million during the quarter, compared to analyst estimates of $38
  • 05 million
Arcutis Biotherapeutics (NASDAQARQT Free Report) had its price target lifted by Mizuho from $19.00 to $20.00 in a research note released on Tuesday,Benzinga reports. They currently have an outperf [+5037 chars]

Must read Articles